Bioceltix SA (XI3) Stock Price & News

All values in PLN	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-	-	-	-
Cost of goods sold	536.06K	533.98K	1.07M	619.84K
Cost of revenue	536.06K	533.98K	1.07M	619.84K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.67M	3.86M	4.62M	4.47M
Operating expense	3.91M	2.88M	4.70M	4.42M
Total operating expenses	4.45M	3.42M	5.77M	5.04M
Operating income	-4.45M	-3.42M	-5.77M	-5.04M
Other non operating income	-	-	-	-38.16K
EBT including unusual items	-4.42M	-3.39M	-5.68M	-5.06M
EBT excluding unusual items	-4.42M	-3.39M	-5.68M	-5.06M
Income tax expense	-40.40K	516.00	-6.97K	12.83K
Effective tax rate	0.91%	-0.02%	0.12%	-0.25%
Other operating expenses	82.21K	-1.14M	-80.02K	-244.11K
Net income	-4.38M	-3.39M	-5.68M	-5.07M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	73.53K	50.46K	136.82K	24.97K
Interest expense	-34.87K	-22.48K	-17.11K	-13.18K
Net interest expenses	38.67K	27.98K	119.71K	11.79K
Depreciation and amortization charges	160.78K	161.63K	161.65K	192.24K
EBITDA	-4.29M	-3.25M	-5.61M	-4.84M
Gain or loss from assets sale	-	-	-	-

Finance